Target intelligence / Profile preview

Chaperone protein DnaK (DnaK) (DnaK)

Target
DnaK
Molecular classification
Enzyme, Chaperone, Heat shock protein
01

Overview

Chaperone protein DnaK is the primary bacterial homolog of the eukaryotic 70 kDa heat shock protein (Hsp70) and serves as a central hub in the bacterial molecular chaperone network [6, 7]. It plays a critical role in protein homeostasis by facilitating the folding of nascent polypeptides, refolding misfolded proteins, and solubilizing protein aggregates, particularly under stress conditions such as heat shock or antibiotic exposure [1, 8, 11]. DnaK functions through an ATP-dependent cycle of substrate binding and release, regulated by co-chaperones DnaJ and the nucleotide exchange factor GrpE [3, 5, 9]. Beyond its role in proteostasis, DnaK is essential for bacterial virulence, biofilm formation, and the development of multi-drug resistance in various pathogens [3, 6, 7, 9]. Interestingly, certain bacterial DnaK proteins, such as those from Mycoplasma, have been implicated in oncogenesis by interfering with the p53 tumor suppressor pathway in host cells [4, 16]. As a therapeutic target, DnaK is being targeted by novel proline-rich antimicrobial peptides (PrAMPs) like Api88 and ARV-1502, which selectively inhibit its activity without affecting human Hsp70, as well as small molecule allosteric inhibitors [6, 10, 13, 16].

Other names
Hsp70 homolog70 kDa heat shock proteinProkaryotic Hsp70Heat shock protein 70
02

Mechanism of action

Inhibition of ATPase activity, prevention of chaperone-assisted protein folding, and disruption of co-chaperone interactions.

03

Biological functions

Protein foldingStress responseProtein homeostasisBiofilm formationVirulence
04

Disease associations

InfectionCancerMulti-drug resistance
05

Safety considerations

Cross-reactivity with human Hsp70Off-target effectsBacterial cell wall permeability
06

Interacting drugs

Api88

8 more in the full profile.

07

Biomarkers

Bacterial loadDnaK expression levelsp53 degradation markers

Beyond the preview

Go deeper on Chaperone protein DnaK (DnaK) (DnaK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chaperone protein DnaK (DnaK) (DnaK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call